Richard Wyss, PhD

Brigham and Women's Hospital, Harvard Medical School
Boston, Massachusetts, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Heterogeneous Treatment Effect of Glucagon-like Peptide 1 Receptor Agonists on Asthma/COPD exacerbation: Machine-learning Analysis of Two Nationwide Cohorts

  Friday, August 26, 2022
  2:00 PM – 2:15 PM CEST

• Comparative Evaluation of Automated Approaches for Confounder Selection in Ultra High-dimensional Data with Rare Outcomes

  Saturday, August 27, 2022
  1:00 PM – 1:15 PM CEST

• Claims-based Model to Predict Obesity in Older Patients

  Saturday, August 27, 2022
  1:45 PM – 2:00 PM CEST

• Cloning, Censoring, and Weighting — Oh My! Applications of Target Trial Emulation for Evaluating Cancer Interventions When Study Eligibility, Intervention Initiation, and Start of Follow-up Are Not Aligned

  Saturday, August 27, 2022
  4:15 PM – 5:45 PM CEST

• Using Iterative Causal Forest to Identify Heterogeneous Treatment Effects: Sodium-glucose Cotransporter-2 inhibitors versus Glucagon-like Peptide-1 Receptor Agonists on Hospitalization for Heart Failure

  Sunday, August 28, 2022
  9:45 AM – 10:00 AM CEST

• The Impact of Electronic Health Record Discontinuity on Prediction Modeling

  Sunday, August 28, 2022
  1:30 PM – 1:35 PM CEST